R. Rodríguez-Roisín
American Journal of Respiratory and Critical Care Medicine · 2000–2017
A researcher in the Science corpus: 11 papers; trusts 0 researchers and is trusted by 7 researchers here, as inferred from the citation graph.
Who trusts R. Rodríguez-Roisín overall
- T. Wilkinson
- J. Wedzicha
- G. Donaldson
- T. Seemungal
- D. Parums
- John R. Hurst
- P. Angeli
- Bartolome Celli
Papers from R. Rodríguez-Roisín's perspective
Ordered by how strongly the researchers R. Rodríguez-Roisín trusts endorse each paper. Same corpus, a different order for every researcher.
- Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. (European Respiratory Journal)
- Epidemiology and costs of chronic obstructive pulmonary disease (European Respiratory Journal)
- Systemic effects of chronic obstructive pulmonary disease (European Respiratory Journal)
- Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. (American Journal of Respiratory and Critical Care Medicine)
- Chronic obstructive pulmonary disease: current burden and future projections (European Respiratory Journal)
- A systematic review of the use of opioids in the management of dyspnoea (Thorax)
- Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. (American Journal of Respiratory and Critical Care Medicine)
- A Clinical Practice Guideline for Treating Tobacco Use and Dependence A US Public Health Service Report
- Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study. (Journal of the American Medical Association (JAMA))
- Global burden of COPD: systematic review and meta-analysis (European Respiratory Journal)
Their papers
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. (2017) — 643 citations
- Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report (2017) — 1,216 citations
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary (2017) — 3,443 citations
- Withdrawal of inhaled glucocorticoids and exacerbations of COPD. (2014) — 611 citations
- Hepatopulmonary syndrome--a liver-induced lung vascular disorder. (2008) — 620 citations
- Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (2007) — 3,539 citations
- Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (2007) — 13,352 citations
- Pulmonary–Hepatic vascular Disorders (PHD) (2004) — 769 citations
- American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias (2002) — 3,677 citations
- Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. (2001) — 698 citations
- Toward a consensus definition for COPD exacerbations. (2000) — 1,010 citations